Licoricesaponin G2CAS# 118441-84-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 118441-84-2 | SDF | Download SDF |
PubChem ID | 14891565 | Appearance | Powder |
Formula | C42H62O17 | M.Wt | 838.93 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6S)-2-[[(3S,4S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | ||
SMILES | CC12CCC(CC1C3=CC(=O)C4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)C(=O)O)O)O)O)C)(C)C(=O)O | ||
Standard InChIKey | WBQVRPYEEYUEBQ-OJVDLISWSA-N | ||
Standard InChI | InChI=1S/C42H62O17/c1-37-11-12-38(2,36(54)55)16-19(37)18-15-20(44)31-39(3)9-8-22(40(4,17-43)21(39)7-10-42(31,6)41(18,5)14-13-37)56-35-30(26(48)25(47)29(58-35)33(52)53)59-34-27(49)23(45)24(46)28(57-34)32(50)51/h15,19,21-31,34-35,43,45-49H,7-14,16-17H2,1-6H3,(H,50,51)(H,52,53)(H,54,55)/t19-,21+,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35+,37+,38-,39-,40+,41+,42+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Licoricesaponin G2 has the anti-inflammatory effects as NF-κB inhibitors. 2. Licoricesaponin G2 has anti-HIV activity via significantly interacted with R15K. |
Targets | HIV | NF-kB |
Licoricesaponin G2 Dilution Calculator
Licoricesaponin G2 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.192 mL | 5.96 mL | 11.9199 mL | 23.8399 mL | 29.7999 mL |
5 mM | 0.2384 mL | 1.192 mL | 2.384 mL | 4.768 mL | 5.96 mL |
10 mM | 0.1192 mL | 0.596 mL | 1.192 mL | 2.384 mL | 2.98 mL |
50 mM | 0.0238 mL | 0.1192 mL | 0.2384 mL | 0.4768 mL | 0.596 mL |
100 mM | 0.0119 mL | 0.0596 mL | 0.1192 mL | 0.2384 mL | 0.298 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- MK 886
Catalog No.:BCC7017
CAS No.:118414-82-7
- nTZDpa
Catalog No.:BCC7268
CAS No.:118414-59-8
- UNC 926 hydrochloride
Catalog No.:BCC2445
CAS No.:1184136-10-4
- AG-18
Catalog No.:BCC1051
CAS No.:118409-57-7
- Trimethylamine oxide
Catalog No.:BCN1819
CAS No.:1184-78-7
- Australine
Catalog No.:BCN2053
CAS No.:118396-02-4
- Licoricesaponin A3
Catalog No.:BCN7905
CAS No.:118325-22-7
- Tazarotene
Catalog No.:BCC2540
CAS No.:118292-40-3
- 6-O-Acetylscandoside
Catalog No.:BCN8320
CAS No.:118292-15-2
- AF-DX 384
Catalog No.:BCC7024
CAS No.:118290-26-9
- Lafutidine
Catalog No.:BCC4544
CAS No.:118288-08-7
- Isodorsmanin A
Catalog No.:BCN6460
CAS No.:118266-99-2
- Arcyriaflavin A
Catalog No.:BCC7370
CAS No.:118458-54-1
- Cyclo(L-Phe-trans-4-hydroxy-L-Pro)
Catalog No.:BCN3989
CAS No.:118477-06-8
- Fmoc-D-Tyr(tBu)-OH
Catalog No.:BCC3569
CAS No.:118488-18-9
- 5,7-Dichlorokynurenic acid sodium salt
Catalog No.:BCC7758
CAS No.:1184986-70-6
- TRIS hydrochloride
Catalog No.:BCC7589
CAS No.:1185-53-1
- Myelin Basic Protein (87-99)
Catalog No.:BCC1028
CAS No.:118506-26-6
- LP 12 hydrochloride
Catalog No.:BCC7517
CAS No.:1185136-22-4
- DPPE fumarate
Catalog No.:BCC5669
CAS No.:1185241-83-1
- Sagittatoside A
Catalog No.:BCN2285
CAS No.:118525-35-2
- Sagittatoside B
Catalog No.:BCN2357
CAS No.:118525-36-3
- Sagittatoside C
Catalog No.:BCN3059
CAS No.:118525-37-4
- Icaritin
Catalog No.:BCN5352
CAS No.:118525-40-9
Rapid screening and identification of active ingredients in licorice extract interacting with V3 loop region of HIV-1 gp120 using ACE and CE-MS.[Pubmed:25854854]
J Pharm Biomed Anal. 2015;111:28-35.
The binding of envelope protein gp120 to glycosphingolipids is very important during the human immunodeficiency virus entering into the host cell. This step occurs in the V3 loop region in particularly. The conserved core sequence of V3 loop in gp120 was named R15K. Anti-HIV drug targeting to R15K would avoid the drug-resistance caused by HIV-1 genetic diversity. Here, for the first time, affinity capillary electrophoresis (ACE) and capillary electrophoresis-mass spectrometry (CE-MS) were used for establishing a simple, rapid and effective method of screening the licorice extract for biological activity (anti-HIV), which avoided the complicated isolation and purification process. R15K, 3'-sialyllactose (the positive control), and d-galactose (the negative control) were used for the development and validation of ACE method. After the interaction between licorice extract and R15K was confirmed by ACE, the relative active ingredients were isolated by SPE and their structures were determined by CE-ESI-MS online. In this research, two mixtures from licorice extract were found to be active. Furthermore, glycyrrhizin and licorice saponin G2 were verified as the main ingredients that significantly interacted with R15K via CE-MS and LC-MS. The results of quantitative assays showed that the active mixture contained glycyrrhizin of 74.23% and licorice saponin G2 of 9.52%. Calculated by Scatchard analysis method, glycyrrhizin/R15K complex had the highest binding constant (1.69 +/- 0.08) x 10(7)L/mol among 27 compounds isolated from licorice extract. The anti-HIV activity of glycyrrhizin was further confirmed by bioactive experiment of cellular level. This strategy might provide a high throughput screening and identifying platform for seeking HIV-1 inhibitors in natural products.